A Big Pharma giant is deepening its investments in China, just as President Donald Trump has been pressuring the drugmaking industry to invest more heavily in US research and manufacturing, and pull back from operations in the world’s largest communist country.
In a statement posted on Eli Lilly & Co.’s Chinese website, Huzur Devletsah, senior vice president of the company and president and general manager of Lilly China, said Beijing remains a central pillar of the company’s long-term China strategy.
Read Full Article: https://amgreatness.com/2026/01/06/pharma-giant-announces-new-investments-in-china/
